EFGCP Switches Annual Congress from January to March

October 1, 2015
Philip Ward

Philip Ward is ACT's European editor, phone +44 1244 538583, philipward1@btconnect.com

Applied Clinical Trials

The European Forum for GCP (EFGCP) has moved its annual two-day conference from the traditional slot in late January to the beginning of March.

Under the title of “Bringing together the two worlds of medicine & device research to better serve public, patients & research participants,” EFGCP Annual Conference 2016 will take place on March 1 and 2, in Brussels, Belgium.

The aim of the event is to help the two worlds of pharma and medical devices develop research, medicines and equipment for patient benefit.

“The EU Medical Device regulations are almost upon us. These will have significant consequences, similar to the Clinical Trail Regulations and there is an opportunity to learn from pharma experience,” noted EFGCP in a statement issued October 1.

The meeting will outline what regulations will mean to the devices industry and focus on the lessons learnt from experience with the clinical trial regulations. The tangible outcomes will be an EFGCP report and recommendations that will be provided to those involved in the legislative process.

For 22 years the European Forum for Good Clinical Practice has acted as a forum to bring patients, researchers, sponsors, competent authorities and ethics committees together and debate current topics. It is recognized as an important forum for multi-stakeholder debate.